Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.61 |
| ▸ | ACP3 | P15309 | 1/20 | 0.60 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.57 |
| ▸ | PGR | P06401 | 1/20 | 0.57 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.57 |
| ▸ | AR | P10275 | 1/20 | 0.57 |
| ▸ | LTA4H | P09960 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13295535 | 1.00 | SLC2A1 (0.61) | SLC2A1ACP3CA4NR3C1PGR | |
| SCHEMBL14205685 | 1.00 | SLC2A1 (0.61) | SLC2A1ACP3CA4NR3C1PGR | |
| SCHEMBL13295540 | 1.00 | SLC2A1 (0.61) | SLC2A1ACP3CA4NR3C1PGR | |
| SCHEMBL40557 | 1.00 | SLC2A1 (0.61) | SLC2A1ACP3CA4NR3C1PGR | |
| SCHEMBL13295537 | 1.00 | SLC2A1 (0.61) | SLC2A1ACP3CA4NR3C1PGR | |
| Hydrochloric Acid SCHEMBL28430528 | 0.98 | SLC2A1 (0.59) | SLC2A1ACP3CA4NR3C1PGR | |
| Hydrochloric Acid SCHEMBL10530921 | 0.98 | SLC2A1 (0.59) | SLC2A1ACP3CA4NR3C1PGR | |
| SCHEMBL28801049 | 0.92 | SLC2A1 (0.53) | SLC2A1ACP3CA4NR3C1PGR | |
| SCHEMBL16203305 | 0.92 | ACHE (0.60) | SLC2A1ACP3CA4NR3C1PGR | |
| SCHEMBL16859725 | 0.90 | SLC2A1 (0.71) | SLC2A1ACP3CA4NR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11207 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043642-B2 | Process for the purification of oligonucleotides | GENENTECH, INC. (US) | 2024-07-23 | — | — | US | claimed |
| WO-2024149093-A1 | GLUCOCORTICOID RECEPTOR AGONIST AND CONJUGATE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-07-18 | — | — | WO | claimed |
| EP-4039690-B1 | A SUBSTANTIALLY DIASTEREOMERICALLY PURE PHOSPHORAMIDOCHLORIDATE, A METHOD AND A PHARMACEUTICAL COMPOSITION | EISAI R&D MAN CO LTD (JP) | 2024-07-17 | — | — | EP | claimed |
| EP-4396193-A1 | FUNCTIONALIZED N-ACETYLGALACTOSAMINE ANALOGS | Hongene Biotech Corporation (US) | 2024-07-10 | — | — | EP | claimed |
| CN-118317970-A | Synthesis of 2' acetyl-ester protected nucleosides | 兆维生物科技公司 | 2024-07-09 | — | — | CN | claimed |
| CN-118290429-A | Preparation method of non-zolpidem intermediate and non-zolpidem | 山东百诺医药股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| EP-4392558-A1 | ANTISENSE OLIGONUCLEOTIDES HAVING ONE OR MORE ABASIC UNITS | Sarepta Therapeutics, Inc. (US) | 2024-07-03 | — | — | EP | claimed |
| CN-118047824-B | Use of dialkylphosphonic acids in oligonucleotide synthesis | 北京瑞博奥医药科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| WO-2024137756-A1 | COMPOUNDS AND METHODS FOR LIQUID PHASE OLIGONUCLEOTIDE SYNTHESIS | HONGENE BIOTECH CORPORATION (US) | 2024-06-27 | — | — | WO | claimed |
| WO-2024135609-A1 | LINKER FOR NUCLEIC ACID SYNTHESIS, CARRIER, AND METHODS FOR PRODUCING SAME | シンクレスト株式会社 | 2024-06-27 | — | — | WO | claimed |
| US-4461906-A | IMPROVING INTELLECTUAL CAPACITY | HOFFMANN-LA ROCHE INC. (US) | 1984-07-24 | — | — | US | claimed |
| US-4452807-A | CENTRAL NERVOUS SYSTEM DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1984-06-05 | — | — | US | claimed |
| US-4407750-A | Unsymmetrical azetidinone aldehyde disulfides and process | ELI LILLY AND COMPANY (US) | 1983-10-04 | — | — | US | claimed |
| US-4394313-A | Symmetrical azetidinone aldehyde disulfides and process | ELI LILLY AND COMPANY (US) | 1983-07-19 | — | — | US | claimed |
| US-4335240-A | Process for cyclization | ELI LILLY AND COMPANY (US) | 1982-06-15 | — | — | US | claimed |
| US-4310662-A | Nucleosidic phosphorylating agent and methods | GENENTECH, INC. (US) | 1982-01-12 | — | — | US | claimed |
| US-4302391-A | Unsymmetrical azetidinone aldehyde disulfides and process | ELI LILLY AND COMPANY (US) | 1981-11-24 | — | — | US | claimed |
| US-4293495-A | Symmetrical azetidinone aldehyde disulfides and process | ELI LILLY AND COMPANY (US) | 1981-10-06 | — | — | US | claimed |
| US-4293493-A | Azetidinone alcohol disulfides and process for cyclization | ELI LILLY AND COMPANY (US) | 1981-10-06 | — | — | US | claimed |
| EP-0002322-A2 | Improved Triester process for the synthesis of oligonucleotides | GENENTECH, INC. (US) | 1979-06-13 | — | — | EP | claimed |